Zobrazeno 1 - 10
of 20
pro vyhledávání: '"James B. O'Keefe"'
Publikováno v:
JMIR Formative Research, Vol 7, p e44250 (2023)
BackgroundIn March 2020, the World Health Organization declared COVID-19 a global pandemic, necessitating an understanding of factors influencing severe disease outcomes. High COVID-19 hospitalization rates underscore the need for robust risk predict
Externí odkaz:
https://doaj.org/article/fd09e0e0515048768b75cb04f1dc6223
Autor:
Theodore M Johnson, Laura C Plantinga, Rebecca Steinberg, Bjorn Anderson, Ziyue Hu, James B O’Keefe, Rishi Kamaleswaran, Blake Anderson
Publikováno v:
BMJ Open Quality, Vol 10, Iss 3 (2021)
Externí odkaz:
https://doaj.org/article/c7c1a4d176b54f1e91ad72b001e59d62
Publikováno v:
BMJ Open, Vol 11, Iss 3 (2021)
Objective Describe the disease course in a cohort of outpatients with COVID-19 and evaluate factors predicting duration of symptoms.Design Retrospective cohort study.Setting Telemedicine clinic at a large medical system in Atlanta, Georgia.Participan
Externí odkaz:
https://doaj.org/article/4ec888575f224e649a7f1a3a8047d70c
Autor:
Natalie S. Haddad, Doan C. Nguyen, Merin E. Kuruvilla, Andrea Morrison-Porter, Fabliha Anam, Kevin S. Cashman, Richard P. Ramonell, Shuya Kyu, Ankur Singh Saini, Monica Cabrera-Mora, Andrew Derrico, David Alter, John D. Roback, Michael Horwath, James B. O’Keefe, Henry M. Wu, An-Kwok Ian Wong, Alexandra W. Dretler, Ria Gripaldo, Andrea N. Lane, Hao Wu, Helen Y. Chu, Saeyun Lee, Mindy Hernandez, Vanessa Engineer, John Varghese, Rahul Patel, Anum Jalal, Victoria French, Ilya Guysenov, Christopher E. Lane, Tesfaye Mengistsu, Katherine Elizabeth Normile, Onike Mnzava, Sang Le, Ignacio Sanz, John L. Daiss, F. Eun-Hyung Lee
Publikováno v:
ImmunoHorizons. 5:322-335
SARS-CoV-2 has caused over 100,000,000 cases and almost 2,500,000 deaths globally. Comprehensive assessment of the multifaceted antiviral Ab response is critical for diagnosis, differentiation of severity, and characterization of long-term immunity,
Autor:
Elizabeth J Tong, Thomas L. Jarrett, James B O'Keefe, Clyde Partin, Jennifer Zreloff, Miranda A Moore, Sharon H Bergquist, David L. Roberts
Publikováno v:
Sn Comprehensive Clinical Medicine
SN Comprehensive Clinical Medicine
SN Comprehensive Clinical Medicine
The characteristics of patients with coronavirus disease 2019 (COVID-19) have primarily been described in hospitalized adults. Characterization of COVID-19 in ambulatory care is needed for a better understanding of its evolving epidemiology. Our aim
Autor:
Mary Morrow, Colin Johnson, Ghazala O'Keefe, Miranda A Moore, Karima Benameur, James B O'Keefe, H. Caroline Minton, Jason Higdon, Jessica K. Fairley
Publikováno v:
Open Forum Infectious Diseases
BackgroundIndividuals with coronavirus disease 2019 (COVID-19) may have persistent symptoms following their acute illness. The prevalence and predictors of these symptoms, termed postacute sequelae of severe acute respiratory syndrome coronavirus 2 (
Autor:
James B O'Keefe
Publikováno v:
Journal of Continuing Education in the Health Professions.
Autor:
Shivan N. Patel, Sarah Furth, Rafi Ahmed, Julie Czartoski, Maria P. Lemos, Kristen W. Cohen, Sivaram Gunisetty, Mehul S. Suthar, Grace Mantus, M. Juliana McElrath, Rustom Antia, James B O'Keefe, Srilatha Edupuganti, Stephen C. De Rosa, Katharine Floyd, Hasan Ahmed, Mohini P. Gharpure, Lindsay E. Nyhoff, Aneesh K. Mehta, Brittany Prigmore, David S. Stephens, Susanne L. Linderman, Evan J. Anderson, Kathy Stephens, Veronika I. Zarnitsyna, Venkata Viswanadh Edara, Lilin Lai, Carson Norwood, Jens Wrammert, Zoe Moodie, Rachael E. Whaley, Nadine Rouphael, Carl W. Davis
Publikováno v:
medRxiv
Cell Reports Medicine
Cell Reports Medicine
Ending the COVID-19 pandemic will require long-lived immunity to SARS-CoV-2. Here, we evaluate 254 COVID-19 patients longitudinally up to 8 months and find durable broad-based immune responses. SARS-CoV-2 spike binding and neutralizing antibodies exh
Publikováno v:
JMIR Public Health and Surveillance, Vol 7, Iss 4, p e25075 (2021)
JMIR Public Health and Surveillance
JMIR Public Health and Surveillance
Background Risk assessment of patients with acute COVID-19 in a telemedicine context is not well described. In settings of large numbers of patients, a risk assessment tool may guide resource allocation not only for patient care but also for maximum
Infection- and vaccine-induced antibody binding and neutralization of the B.1.351 SARS-CoV-2 variant
Autor:
Rafi Ahmed, Nadine Rouphael, Katharine Floyd, Carson Norwood, James B O'Keefe, Srilatha Edupuganti, Lindsay E. Nyhoff, Jacob Usher, Dumingu Nipuni Gomes, Rebecca Fineman, Anne Piantadosi, Jamila Pitts, Meredith E. Davis-Gardner, Hayatu Abdullahi, Nina N. McNair, Grace Mantus, Rebecca Byram, Kieffer Hellmeister, Jens Wrammert, Shivan N. Patel, Bernadine Panganiban, Max W. Adelman, Nour Beydoun, Venkata Viswanadh Edara, Garett Michael, Evan J. Anderson, David S. Stephens, Mehul S. Suthar, Jennifer Kleinhenz, Ahmed Babiker, Joy Winters, William H. Hudson, Lilin Lai, Jesse J. Waggoner
Publikováno v:
bioRxiv
The emergence of SARS-CoV-2 variants with mutations in the spike protein is raising concerns about the efficacy of infection- or vaccine-induced antibodies. We compared antibody binding and live virus neutralization of sera from naturally infected an